Supplementary Figure S3 from Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial)
Authors
Tom Schulz (ORCID: https://orcid.org/0000-0003-4070-7791)
Christoph K.W. Deinzer (ORCID: https://orcid.org/0009-0006-1961-9382)
Philipp Ivanyi (ORCID: https://orcid.org/0000-0002-2862-7302)
Sebastian Bauer (ORCID: https://orcid.org/0000-0001-5949-8120)
Supplementary Figure S3 from Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial)
Tom Schulz, Christoph K.W. Deinzer, Philipp Ivanyi, Sebastian Bauer et al.
Topics
Gastrointestinal Tumor Research and Treatment
article
Supplementary Figure S3 from Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial)
Tom Schulz, Christoph K.W. Deinzer, Philipp Ivanyi, Sebastian Bauer, Adrián Mariño‐Enríquez, Daniel Pink, Valerie Haller, Peter Hohenberger, Peter Reichardt, Benjamin S. Fletcher, Thomas Mühlenberg, Johanna Falkenhorst, Daniel Rauh, Bernd Kasper, Rainer Hamacher, Yasmin Optaczy, Susanne Grünewald